Bafna [BAFNAPH] vs Vaishali Pharma [VAISHALI] Detailed Stock Comparison

Bafna Pharmaceuticals Ltd.

NSE
Loading...

Vaishali Pharma Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Bafna Pharmaceuticals Ltd. wins in 12 metrics, Vaishali Pharma Ltd. wins in 6 metrics, with 0 ties. Bafna Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bafna Pharmaceuticals Ltd. Vaishali Pharma Ltd. Better
P/E Ratio (TTM) 32.31 133.83 Bafna Pharmaceuticals Ltd.
Price-to-Book Ratio 3.43 1.57 Vaishali Pharma Ltd.
Debt-to-Equity Ratio 35.52 23.15 Vaishali Pharma Ltd.
PEG Ratio 0.34 N/A N/A
EV/EBITDA 21.81 -60.31 Bafna Pharmaceuticals Ltd.
Profit Margin (TTM) 6.55% -0.45% Bafna Pharmaceuticals Ltd.
Operating Margin (TTM) 3.87% 5.81% Vaishali Pharma Ltd.
EBITDA Margin (TTM) 3.87% 5.81% Vaishali Pharma Ltd.
Return on Equity 4.90% 1.26% Bafna Pharmaceuticals Ltd.
Return on Assets (TTM) 2.71% 0.74% Bafna Pharmaceuticals Ltd.
Free Cash Flow (TTM) $2.76M $-183.43M Bafna Pharmaceuticals Ltd.
1-Year Return 138.52% -43.21% Bafna Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 2.18 0.92 Vaishali Pharma Ltd.
Enterprise Value $3.53B $1.24B Bafna Pharmaceuticals Ltd.
EV/Revenue Ratio 2.40 1.09 Vaishali Pharma Ltd.
Gross Profit Margin (TTM) 28.78% 1.47% Bafna Pharmaceuticals Ltd.
Revenue per Share (TTM) $62 $10 Bafna Pharmaceuticals Ltd.
Earnings per Share (Diluted) $4.09 $0.06 Bafna Pharmaceuticals Ltd.
Beta (Stock Volatility) -0.02 -0.01 Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. vs Vaishali Pharma Ltd. Stock Performance Analysis

Loading Price Chart...

BAFNAPH
VAISHALI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bafna Pharmaceuticals Ltd.-10.00%40.06%46.95%81.30%38.27%30.72%
Vaishali Pharma Ltd.-0.68%3.84%-2.28%12.14%-12.57%-14.52%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bafna Pharmaceuticals Ltd.138.52%41.70%23.53%513.36%277.60%277.60%
Vaishali Pharma Ltd.-43.21%-44.55%73.75%72.10%72.10%72.10%

Performance & Financial Health Analysis: Bafna Pharmaceuticals Ltd. vs Vaishali Pharma Ltd.

MetricBAFNAPHVAISHALI
Market Information
Market Cap i₹3.34B₹1.05B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i6,280871,885
90 Day Avg. Volume i5,379455,768
Last Close₹174.58₹7.25
52 Week Range₹72.01 - ₹213.36₹4.75 - ₹13.59
% from 52W High-18.18%-46.65%
All-Time High₹233.55 (Dec 14, 2020)₹24.91 (Oct 14, 2024)
% from All-Time High-25.25%-70.90%
Growth Metrics
Quarterly Revenue Growth0.15%-0.12%
Quarterly Earnings Growth0.94%-0.09%
Financial Health
Profit Margin (TTM) i0.07%0.00%
Operating Margin (TTM) i0.04%0.06%
Return on Equity (TTM) i0.05%0.01%
Debt to Equity (MRQ) i35.5223.15
Cash & Liquidity
Book Value per Share (MRQ)₹38.54₹5.11
Cash per Share (MRQ)₹0.11₹0.08
Operating Cash Flow (TTM) i₹207.66M₹-326,443,000
Levered Free Cash Flow (TTM) i₹41.53M₹8.17M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Bafna Pharmaceuticals Ltd. vs Vaishali Pharma Ltd.

MetricBAFNAPH (Apr 24, 2026)VAISHALI (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i32.31133.83
Forward P/E iN/AN/A
PEG Ratio i0.34N/A
Price to Sales (TTM) i2.180.92
Price to Book (MRQ) i3.431.57
Market Capitalization
Market Capitalization i₹3.34B₹1.05B
Enterprise Value i₹3.53B₹1.24B
Enterprise Value Metrics
Enterprise to Revenue i2.401.09
Enterprise to EBITDA i21.81-60.31
Risk & Other Metrics
Beta i-0.02-0.01
Book Value per Share (MRQ) i₹38.54₹5.11

Financial Statements Comparison: Bafna Pharmaceuticals Ltd. vs Vaishali Pharma Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBAFNAPH (2025)VAISHALI (2025)
Revenue/Sales i1.46B978.82M
Cost of Goods Sold i1.03B856.75M
COGS % of Revenue i70.7%87.5%
Gross Profit i427.96M122.07M
Gross Margin i29.3%12.5%
Research & Development i14.54MN/A
Operating Income (EBIT) i69.62M59.00M
Operating Margin i4.8%6.0%
EBITDA i136.10M93.22M
EBITDA Margin i9.3%9.5%
Pre-Tax Income i41.53M12.26M
Pre-Tax Income % of Revenue i2.8%1.3%
Income Tax i04.08M
Income Tax % of Revenue i0.0%0.4%
Net Income (Profit) i41.53M8.17M
Profit Margin i2.8%0.8%

Balance Sheet & Liquidity Metrics

MetricBAFNAPH (2025)VAISHALI (2025)
Cash & Equivalents i34.33M17.11M
Total Current Assets i847.28M1.04B
Total Current Assets % of Revenue i58.1%106.7%
Total Current Liabilities i518.52M400.53M
Total Current Liabilities % of Revenue i35.5%40.9%
Long-Term Debt i140.29M46.19M
Long-Term Debt % of Revenue i9.6%4.7%
Total Shareholders Equity i848.07M649.16M
Retained Earnings i-431.31M157.29M
Retained Earnings % of Revenue i-29.6%16.1%
Property, Plant & Equipment i192.19M0

Cash Flow Statement Comparison

MetricBAFNAPH (2025)VAISHALI (2025)
Operating Cash Flow i207.66M-326.44M
Operating Cash Flow % of Revenue i14.2%-33.4%
Capital Expenditures i-218.01M-3.05M
Free Cash Flow i2.76M-183.43M
FCF Margin i0.2%-18.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBAFNAPHVAISHALI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i23.66M130.46M
Float Shares i3.33M68.14M
% Held by Insiders i90.22%N/A
% Held by Institutions i0.00%N/A
% Held by Public i9.78%N/A

Dividend Analysis & Yield Comparison: Bafna Pharmaceuticals Ltd. vs Vaishali Pharma Ltd.

MetricBAFNAPHVAISHALI
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A